Table 1.
Summary of biomedical applications of functional chitosan and its derivative-related nano-biodevices.
| Biomedical Applications | Examples of Nano-Biodevices | Available Multi-Properties for Design | Refs. | 
|---|---|---|---|
| Anti-tumor | DOX-encapsulated polymeric nanoparticle surface-decorated with chitosan | 
 | [87] | 
| DOX-loaded and aptamer-mesoporous silica nanoparticle (MSN) bioconjugates coated with chitosan (Dox-Chi-MSNs) | [88] | ||
| In situ injectable nanocomposite hydrogel | [89] | ||
| Glycol chitosan nanoparticles | [91] | ||
| Antimicrobial | Injectable quaternary ammonium chitosan (QCS)/tannic acid (TA) hydrogel | 
 | [93] | 
| Chitosan (CS)/citric acid (CA)/silver (Ag) cryogel | [95] | ||
| CS-ZnO (zinc oxide particles)/Ce6 (chlorin) sponge | [97] | ||
| Chitosan-based dual-functional platform for ocular topical delivery of econazole | [103] | ||
| Mucosal drug delivery | Mannose-anchored quaternized chitosan/thiolated carboxymethyl chitosan composite nanoparticles (M-N-2-HACC/BSA/N-CMCS NPs) | 
 | [105] | 
| Bilirubin (BR)-attached low-molecular-weight, water-soluble chitosan nanoparticles (LMWC-BRNPs) | [106] | ||
| Mussel-inspired, chitosan-catechol adhesive patches (Chitoral) | [107] | ||
| In situ gelling starch nanoparticle (SNP)/O-carboxymethyl chitosan (CMCh) nanoparticle network hydrogel | [110] | ||
| Oral delivery | Polylysine and poly(lactide) co-modified thiolated chitosan/paclitaxel (PY-CS-PLA/PTX) | 
 | [112] | 
| Chitosan and insulin-loaded, zein-carboxymethylated short-chain amylose nanocomposites (IN-Z-CSA/CS) | [115] | ||
| Transdermal drug delivery | Transdermal glipizide delivery system based on chitosan-coated deformable liposomes (GLP-CS-DL1) | 
 | [118] |